Oliver Dorigo, MD – Obstetrician-Gynecologist in Palo Alto

Oliver Dorigo, MD, is an obstetrician-gynecologist in Palo Alto who specializes in Gynecologic Neoplasms. He is affiliated with Stanford Health Care.

Dorigo’s research encompasses clinical evaluation of PARP inhibitors and cell therapy treatments in patients with ovarian cancer. He directs both Stanford’s Gynecologic Oncology Clinical Care Program and Mary Lake Polan Gynecologic Oncology Research Laboratory.

Early Life and Education

Oliver Dorigo studied medicine at Ruprecht Karl University Faculty of Medicine in Munich, Germany and earned his medical degree. Following this, he decided to continue his medical career at UCLA Medical Center/Cedars-Sinai where he completed both an OB/GYN residency and combined gynecologic oncology fellowship – earning himself a PhD through their Specialty Training and Advanced Research (STAR) program by working on cloning viral systems that allow genes to be transferred directly into cells.

As an Associate Professor at Stanford University Medical Center, Dr. Alvarado has extensive experience working in ovarian cancer and overseeing its clinical program while conducting various trials related to this condition.

Dr. Dorigo can speak both English and French fluently and accept various insurance providers.

Professional Career

Oliver Dorigo MD is an OB/GYN in California who specializes in Gynecologic Oncology. With two offices located within California and accepting various insurance providers as patients, Dr. Dorigo accepts new patients regularly.

Once he completed his OB/GYN residency at UCLA, Dorigo continued working in cancer research. He earned a PhD in molecular biology by developing a gene transfer system.

He currently serves as Director and Professor of Stanford University’s Division of Gynecologic Oncology, leading both clinical trials in this specialty as well as laboratory research into new immunotherapeutic strategies for treating ovarian cancer with cell and mouse models, such as his recent trial using an oncolytic virus against it.

Achievement and Honors

Oliver Dorigo is Director of Gynecologic Oncology and Associate Professor at Stanford University Medical Center. An internationally acclaimed leader in ovarian cancer care, Oliver has spearheaded multiple clinical trials that are now standard of care. His research is focused on immunotherapy – specifically vaccines and cell therapy. He is one of the few researchers who has taken their discovery from bench to bedside by conducting an active clinical trial with oncolytic viruses as immunotherapy for women with ovarian cancer. He is also the founding Director of the Mary Lake Polan Gynecologic Cancer Research Laboratory and has established a thriving gynecologic oncology clinical program at Stanford. Furthermore, he has published extensively in ovarian cancer and cell therapy research fields.

Personal Life

Oliver Dorigo, MD is an oncology specialist practicing in Palo Alto, CA. After graduating from Other in 1989, Dr. Dorigo joined Stanford Health Care where he is affiliated with Stanford University Medical Center and accepts multiple insurance plans for practice.

He enjoys an exceptional patient satisfaction rating and is dedicated to creating innovative new therapies for women living with gynecologic cancer. His efforts focus both on clinical trial design as well as preclinical research; and as director of both Mary Lake Polan Gynecologic Oncology Research Laboratory and Stanford Gynecological Oncology Clinical Care Program he plays an essential role.

He is an active participant in multiple medical organizations, such as the Society of Gynecologic Oncology and American College of Obstetricians and Gynecologists. Additionally, he has presented at several national conferences and symposiums.